Q3 2010

Filed Nov 16, 2010 · 10-Q · 45 days after period end · 0001193125-10-261437

Q3 2010 · 10-Q

Revenue

$1.56M

no prior Q3 2009 on file

Net Income

-$883.22K

no prior Q3 2009 on file

EPS Diluted

-$0.01

no prior Q3 2009 on file

Gross Profit$502,726—

Operating Income

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Oct 2, 2010 · filed Nov 16, 2010 · 45 d after period end

Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR